Cutibacterium acnes peptidoglycan cell wall (C. acnes peptidoglycan)

The peptidoglycan cell wall of Cutibacterium acnes (formerly Propionibacterium acnes) is a complex, rigid polymer consisting of glycan chains cross-linked by short peptides, providing essential structural support and osmotic protection to the bacterium. In the context of human health, this structure serves as a major pathogen-associated molecular pattern (PAMP) that is recognized by the innate immune system through receptors such as Toll-like receptor 2 (TLR2) and NOD2. This recognition triggers the release of pro-inflammatory cytokines, including IL-1β, IL-8, and IL-12, which are central to the pathogenesis of inflammatory acne vulgaris. Therapeutic interventions often target the synthesis or integrity of this cell wall; for instance, beta-lactam antibiotics inhibit the transpeptidase enzymes responsible for cross-linking the peptidoglycan layers, leading to bacterial lysis. Furthermore, the persistence of peptidoglycan fragments in tissues has been implicated in chronic inflammatory conditions like sarcoidosis, making its degradation or the inhibition of its synthesis a key focus for dermatological and infectious disease research.

Other names

Propionibacterium acnes peptidoglycanMureinBacterial cell wallC. acnes cell wall

Inhibition of peptidoglycan cross-linking (transpeptidation) via penicillin-binding proteins (PBPs); Inhibition of cell wall precursor transport; Enzymatic degradation of the glycan backbone; Binding to D-Ala-D-Ala precursors to prevent polymerization.